Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere shortening has been implicated in hepatocyte senescence94 and in disease progression in patients with liver cirrhosis95.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [94]
In the citing paper
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers160.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [160]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescence-associated -Gal staining was performed as described previously (18).”
BackgroundMethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Continuous shortening of telomeres during each cell division limits the life span of primary human cells in vitro (6).”
BackgroundHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 3×
“Cirrhosis samples were grouped into samples with mild fibrosis and samples with severe fibrosis according to the Ishak criteria (19).”
MethodInfluentialStructure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · cited 1×
“The tumor suppressor p53 has been identified as a downstream target of short dysfunctional telomeres in mouse (34) and human cells (35).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo
Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., & Harley, C. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1306 · Cited by 533 · cited 2×
“It is still a matter of debate to what extent telomere shortening affects organo-pathophysiology during aging (7) or chronic diseases that induce elevated rates of cell turnover (8–11).”
BackgroundTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCurrent Protocols in Cell Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 502
Research works printed but not linked: 1
- Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000
Cited by
Items 301–400 of 547
Cellular senescence and liver disease: Mechanisms and therapeutic strategies
Guo, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.075 · Cited by 20
Proteins induced by telomere dysfunction are associated with human IgA nephropathy
Lu, Y., Yáng, X., Chen, W., Ju, Z., Shou, Z., Jin, J. F., Zhang, X., Chen, J., & Jiang, H. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300115 · Cited by 18
“Previously, we have found that these biomarkers increased in humans with liver cirrhosis or myelodysplatic syndrome diseases, which also proved to be associated with telomere shortening (Ohyashiki et al., 1994; Wiemann et al., 2002).”
BackgroundKim, T. R., Lee, H. M., Lee, S. Y., Kim, E. J., Kim, K. C., Paik, S. G., Cho, E., & Kim, I. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.018 · Cited by 20
Natural regression of fibrosis in chronic hepatitis B
Ohkoshi, S., Hirono, H., Watanabe, K., Hasegawa, K., Kamimura, K., & Yano, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i24.5459 · Cited by 19
Charlton, M. (2003) · Liver Transplantation · doi:10.1002/lt.500090516 · Cited by 18
Flensted-Jensen, M., Oró, D., Rørbeck, E. A., Zhang, C., Madsen, M. R., Madsen, A. N., Norlin, J., Feigh, M., Larsen, S., & Hansen, H. H. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03141-x · Cited by 17
“NAFLD patients have been reported to show shortened telomere length and increased expression of markers of cell cycle arrest/ DNA damage, including p53, 53BPI, p21 and γH2AX [35, 56–58].”
BackgroundHepatic progenitors in liver regeneration
Raven, A., & Forbes, S. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.004 · Cited by 17
Ho, T.-C., Wang, E.-Y., Yeh, K., Jeng, Y., Horng, J.-H., Wu, L., Chen, Y.-T., Huang, H., Hsu, C., Chen, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918028117 · Cited by 25
“The accumulation of senescent hepatocytes has been demonstrated in most advanced chronic liver diseases (10) and affects”
BackgroundGonzález, E., Azkargorta, M., Garcia‐Vallicrosa, C., Elordui, J. P., Elortza, F., Blanco-Sampascual, S., & Falcón‐Pérez, J. M. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59725 · Cited by 17
Therapeutic interventions of acute and chronic liver disorders: A comprehensive review
Ali, F. E. M., El‐Aziz, M. K. A., Sharab, E. I., & Bakr, A. G. (2023) · World Journal of Hepatology · doi:10.4254/wjh.v15.i1.19 · Cited by 18
Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis
Karidis, N. P., Delladetsima, I. K., & Theocharis, S. E. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/654105 · Cited by 17
Biliary Epithelial Apoptosis, Autophagy, and Senescence in Primary Biliary Cirrhosis
Sasaki, M., & Nakanuma, Y. (2010) · Hepatitis Research and Treatment · doi:10.1155/2010/205128 · Cited by 17
Dong, K., Zhang, Y., Huang, J., Xia, S.-S., & Yang, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.10 · Cited by 16
Invernizzi, P., Bernuzzi, F., Lleò, A., Pozzoli, V., Bignotto, M., Zermiani, P., Crosignani, A. L., Battezzati, P. M., Zuin, M. G., Podda, M., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.11.008 · Cited by 15
Telomere length and cancer mortality in American Indians: the Strong Heart Study
Subedi, P., Nembrini, S., An, Q., Zhu, Y., Peng, H. Y., Yeh, F., Cole, S. A., Rhoades, D. A., Lee, E. T., & Zhao, J. (2019) · GeroScience · doi:10.1007/s11357-019-00080-4 · Cited by 15
Senescence in RASopathies, a possible novel contributor to a complex pathophenoype
Engler, M., Fidan, M., Nandi, S., & Cirstea, I. C. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111411 · Cited by 16
“Senescence in hepatocytes was reported to correlate with fat accumulation and the underlying mechanism is related to an impaired mitochondrial utilisation of fatty acids (Aravinthan et al., 2013; Ogrodnik et al., 2017; Wiemann et al., 2002).”
Pizaño, M. Y. M., Loera‐Arias, M. D. J., Montes‐de‐Oca‐Luna, R., Cárdenas, O. S., Ventura‐Juárez, J., & Muñoz‐Ortega, M. H. (2023) · Annals of Medicine · doi:10.1080/07853890.2022.2164047 · Cited by 17
“The pathophysiology of cirrhosis has recently been explained uniquely by the discovery that hepatocyte telomere shortening, and senescence can cause fibrotic scarring at the cirrhosis stage [48].”
BackgroundLinks between telomere dysfunction and hallmarks of aging
Li, S., Liu, Z., Zhang, J., & Li, L. (2023) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2023.503617 · Cited by 16
Senescence and senotherapies in biliary atresia and biliary cirrhosis
Jannone, G., Bonaccorsi‐Riani, E., de Magnée, C., Tambucci, R., Evraerts, J., Ravau, J., Baldin, P., Bouzin, C., Loriot, A. E., Gatto, L., et al. (2023) · Aging · doi:10.18632/aging.204700 · Cited by 17
Senescent hepatic stellate cells drive inflammation and disease progression in MASH (Review)
Han, Z., She, Y., Wu, D., Zhang, N., Liu, Z., Wang, Z., Zhou, X., & Li, S. (2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2026.13090 · Cited by 15
Telomere dysfunction in chronic liver disease: The link from aging
Penrice, D. D., Jalan‐Sakrikar, N., Jurk, D., Passos, J. F., & Simonetto, D. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000426 · Cited by 17
Molina-Carrión, S., Brochado‐Kith, O., González‐García, J., Berenguer, J., Díez, C., Llop, E., Hontañón, V., Ibáñez, L., Montes, M., Resino, S., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082407 · Cited by 14
“In the liver, hepatocyte telomeres are shorter in cirrhotic patients [8].”
BackgroundCho, K., Bahuguna, A., Kang, D.-J., & Kim, J.-E. (2024) · Antioxidants · doi:10.3390/antiox13010123 · Cited by 14
Cells of origin and cancer stem cells in cholangiocarcinoma
Carpino, G., Cardinale, V., Reid, L. M., Alvaro, D., & Gaudio, E. (2012) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.3978/j.issn.2224-4778.2011.11.03 · Cited by 15
ELISA for Aging Biomarkers Induced by Telomere Dysfunction in Human Plasma
Jiang, H., Chen, W., Qu, L., Chen, Y., He, Q., Wang, H., Wu, J., Shou, Z., Ju, Z., & Chen, J. (2010) · BioMed Research International · doi:10.1155/2010/121947 · Cited by 17
Meyer, D. H., & Bailis, A. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003318 · Cited by 16
Regeneration of the Exocrine Pancreas Is Delayed in Telomere-Dysfunctional Mice
von Figura, G., Wagner, M., Nalapareddy, K., Hartmann, D., Kleger, A., Guachalla, L. M., Rolyan, H., Adler, G., & Rudolph, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017122 · Cited by 13
Self-citationMoreira, R. K. (2011) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31822a5a10 · Cited by 16
Contribution of mononuclear bone marrow cells to carbon tetrachloride-induced liver fibrosis in rats
Cao, B., Lin, J., Zhong, Y., Huang, S., Lin, N., Tang, Z., Chen, R., Xiang, P., & Xu, R.-Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i12.1851 · Cited by 13
Hepatocarcinoma in Viral and Metabolic Liver Disease
Rosenthal, P. J. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318158799b · Cited by 13
Hepatitis C and pulmonary fibrosis
Okutan, O., & Ayten, Ö. (2017) · Tuberkuloz ve Toraks · doi:10.5578/tt.35288 · Cited by 13
Global mapping of transcription factor motifs in human aging
Alfego, D., Rodeck, U., & Kriete, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190457 · Cited by 14
“Telomere shortening, senescence and chronic inflammation are known hallmarks of liver aging [58, 59].”
Cancers and the concept of cell senescence
Macieira‐Coelho, A. (2009) · Biogerontology · doi:10.1007/s10522-009-9241-3 · Cited by 13
“Terminal post-mitotic cells are also a feature of post-radiation fibrosis (Herskind and Rodemann 2000) and of liver cirrhosis ( Wiemann et al. 2002 ).”
BackgroundNguyen, H. B., Le, X.-T. T., Nguyen, H. H., Vo, T. T., Le, K. M., Nguyen, N. T., Do-Nguyen, T. M., Truong-Nguyen, C. M., & Nguyen, S. T.-B. (2022) · Cancer Informatics · doi:10.1177/11769351221100730 · Cited by 12
Keeping your senescent cells under control
Zender, L., & Rudolph, K. L. (2009) · Aging · doi:10.18632/aging.100046 · Cited by 13
Self-citationFernandez, R. J., & Johnson, F. B. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13692 · Cited by 12
Nevi, L., Costantini, D., Safarikia, S., Matteo, S. D., Melandro, F., Berloco, P. B., & Cardinale, V. (2019) · Cells · doi:10.3390/cells8111443 · Cited by 12
Biliary Epithelial Senescence in Cellular Rejection Following Live Donor Liver Transplantation
Rastogi, A., Nigam, N., Ramakrishna, G., Bihari, C., & Pamecha, V. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.08.004 · Cited by 12
Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention
Atkinson, S. P., & Keith, W. N. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000269 · Cited by 13
Correction: Cellular Senescence in Livers from Children with End Stage Liver Disease
Gutiérrez‐Reyes, G., de León, M. D. C. G., Varela‐Fascinetto, G., Valencia, P., Tamayo, R. P., Rosado, C. G., Farfán-Labonne, B. E., Rochilin, N. M., Martínez-García, R., Aguirre-Valádez, J., et al. (2010) · PLoS ONE · doi:10.1371/annotation/6082f3f8-2b92-42a2-8d6f-b9210d2f25bf · Cited by 12
Choi, Y., Kim, M. S., Rhoades, J. H., Johnson, N. M., Berry, C. T., Root, S., Chen, Q., Tian, Y., Fernandez, R. J., Cramer, Z., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.06.003 · Cited by 11
de Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
“Telomere shortening correlated with expression of the cellular senescence marker b -galactosidase and was restricted to hepatocytes and was not observed in other cells in the liver, such as lymphocytes or stellate cells in areas of fi brosis (17).”
BackgroundTometten, M., Kirschner, M., Isfort, S., Berres, M., Brümmendorf, T. H., & Beier, F. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-02024-8 · Cited by 11
Wan, S., Hann, H., Ye, Z., Hann, R. S., Lai, Y., Wang, C., Li, L., Myers, R. E., Li, B., Xing, J., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx021 · Cited by 14
Short Telomeres: Cause and Consequence in Liver Disease
Penrice, D. D., & Simonetto, D. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1713007 · Cited by 12
Nakajima, T., Nakashima, T., Yamaoka, J., Shibuya, A., Konishi, E., Okada, Y., Jo, M., Nishikawa, T., Itoh, Y., & Yoshikawa, T. (2011) · Pathology International · doi:10.1111/j.1440-1827.2011.02743.x · Cited by 11
Tumor size-independence of telomere length indicates an aggressive feature of HCC
Nakajima, T., Katagishi, T., Moriguchi, M., Sekoguchi, S., Nishikawa, T., Takashima, H., Watanabe, T., Kimura, H., Minami, M., Itoh, Y., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.152 · Cited by 11
Templin, C., Kotlarz, D., Rathinam, C., Rudolph, C., Schaetzlein, S., Ramireddy, K., Rudolph, K. L., Schlegelberger, B., Klein, C., & Drexler, H. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2007.10.005 · Cited by 14
Self-citationJeong, S., Cho, Y., Park, S. M., & Kim, W. K. (2021) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001548 · Cited by 10
Xue, Y., Chen, P., Yi, W., Ruan, W., & Xiong, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1029872 · Cited by 9
Molecular Mechanisms of Hepatocellular Carcinoma
Alotaibi, H., Atabey, N., Diril, M. K., Erdal, E., & Öztürk, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_3 · Cited by 10
Maloberti, T., Leo, A. D., Sanza, V., Gruppioni, E., Altimari, A., Riefolo, M., Visani, M., Malvi, D., D’Errico, A., Tallini, G., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i25.2854 · Cited by 10
Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study
Pavanello, S., Varesco, L., Gismondi, V., Bruzzi, P., & Bolognesi, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197522 · Cited by 11
Senescent cells in the development of cardiometabolic disease
Postmus, A. C., Sturmlechner, I., Jonker, J. W., van Deursen, J. M., van de Sluis, B., & Kruit, J. K. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000602 · Cited by 10
Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data
Tornesello, M. L., Tornesello, A. L., Starita, N., Cerasuolo, A., Izzo, F., Buonaguro, L., & Buonaguro, F. M. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2147062 · Cited by 9
Li, Q., Zhang, T., Che, F., Yao, S., Gao, F., Nie, L., Tang, H., Wei, Y., & Song, B. (2023) · European Radiology · doi:10.1007/s00330-023-09496-1 · Cited by 9
“It may be because that the shortening of the hepatocyte telomeres due to liver fibrosis can cause a decrease in the number of cell divisions in primary human cells, finally limiting LR [32].”
BackgroundContributions of Telomere Biology to Human Age-Related Disease
Yang, T.-L., Song, S., & Johnson, F. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00007-1 · Cited by 11
“Small Hepatocytes” in the Liver
Mitaka, T., Ichinohe, N., & Tanimizu, N. (2023) · Cells · doi:10.3390/cells12232718 · Cited by 10
“Growth regulators of small hepatocytes.”
Reece, A. S. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00123.x · Cited by 9
The Szilard Hypothesis on the Nature of Aging Revisited
Zetterberg, H., Båth, M., Zetterberg, M., Bernhardt, P., & Hammarsten, O. (2009) · Genetics · doi:10.1534/genetics.109.103341 · Cited by 12
A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis
Rabindranath, M., Zaya, R., Prayitno, K., Orchanian‐Cheff, A., Patel, K., Jaeckel, E., & Bhat, M. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001547 · Cited by 8
“62 Similar observations were made in murine models whereby NASH-afflicted hepatocytes had shortened telomeres, high γ -H2AX, increased levels of CDK4, and decreased levels of Mcm2, cyclin A, and PH3, which are all indicative of G1/S arrest.”
BackgroundHigh-throughput single telomere analysis using DNA microarray and fluorescent in situ hybridization
Zheng, Y., Wu, X., Williams, M., Verhulst, S., Lin, J., Takahashi, Y., Ma, J., & Wang, Y. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae812 · Cited by 9
“Short telomere length has been implicated as a risk factor in pulmonary disease ( 19–21 ), diabetes mellitus ( 22–24 ), liver cirrhosis ( 25 ,26 ), osteoporosis ( 27 ,28 ), kidney disease ( 29 ,30 ), Alzheimer’s disease ( 31 ,32 ), cardiovascular disease ( 33 ,34 ), and cancer ( 35 ,36 ).”
Deevska, G. M., Dotson, P. P., Mitov, M. I., Butterfield, D. A., & Nikolova‐Karakashian, M. (2021) · Cells · doi:10.3390/cells10061278 · Cited by 9
Major genomic mutations driving hepatocellular carcinoma
Chen, R., Lin, M., & Gao, D. (2023) · Genome Instability & Disease · doi:10.1007/s42764-023-00103-7 · Cited by 10
Growth factors enhance liver regeneration in acute-on-chronic liver failure
Kedarisetty, C. K., Anand, L., Khanam, A., Kumar, A., Rastogi, A., Maiwall, R., & Sarin, S. K. (2014) · Hepatology International · doi:10.1007/s12072-014-9538-4 · Cited by 8
Huang, E., Xu, K., Gu, X., & Zhu, Q. (2021) · Cytogenetic and Genome Research · doi:10.1159/000518284 · Cited by 8
Telomerase as a Target for Cancer Therapeutics
Shay, J. W. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6102-0_13 · Cited by 10
Prognostic value of telomere length: The long and short of it
Rando, T. A. (2006) · Annals of Neurology · doi:10.1002/ana.20927 · Cited by 10
Genetic and Cellular Contributions to Liver Regeneration
Liang, R. J., Lin, Y.-H., & Zhu, H. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040832 · Cited by 9
Lim, Y.-S., Nguyen, M. T. N., Thuy, P. X., Trang, H. T. X., Park, E.-M., Choi, D. H., Kang, S., Tark, D., & Hwang, S. B. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0167 · Cited by 7
Laish, I., Katz, H., Stein, A., Liberman, M., Naftali, T., Kitay‐Cohen, Y., Biron‐Shental, T., Konikoff, F. M., & Amiel, A. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.002 · Cited by 8
“Thus, many studies have observed that accelerated telomere loss is a common feature of systemic autoimmune disease, such as systemic lupus erythematosus or rheumatoid arthritis [37], and local or systemic fibrotic conditions, such as scleroderma [38], idiopathic pulmonary fibrosis [39] and cirrhosis [32, 36].”
BackgroundCachem, F. C. O. F., Dias, A., Monteiro, C., Fernandes, G., Delphim, L., Tavares, F., Maciel, A. M. D. A., Pires, M. M. A., Brandão‐Mello, C. E., de Andrade, R. M., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.023 · Cited by 7
Breathe it in – Spotlight on senescence and regeneration in the lung
Majewska, J., & Krizhanovsky, V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111550 · Cited by 7
Trépo, E., Zucman‐Rossi, J., & Nault, J. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01175-y · Cited by 6
“However, although telomere shortening is observed in cirrhosis, telomerase reactivation is necessary to enable the malignant transformation of cirrhotic hepatocytes and to maintain telomere length in cells undergoing uncontrolled division 102,103,115 (Fig.”
Baliou, S., Spanakis, M., Apetroaei, M.-M., Ιωάννου, Π., Fragkiadaki, P., Fragkiadoulaki, I., Renieri, E. A., Vakonaki, E., Tzatzarakis, M. N., Nosyrev, A. E., et al. (2025) · World Academy of Sciences Journal · doi:10.3892/wasj.2025.344 · Cited by 6
Zhang, T., Li, Q., Wei, Y., Yao, S., Yuan, Y., Deng, L., Wu, D., Nie, L., Wei, X., Tang, H., et al. (2022) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-306 · Cited by 6
Bao, L., Zhou, Y., Shu, J., Li, H., Xi, S., Xu, M., Cai, Q., Dai, X., Zeng, Y., & Zeng, F. (2024) · Theriogenology · doi:10.1016/j.theriogenology.2024.05.019 · Cited by 6
Civan, J. M., & Hann, H. (2014) · North American Journal of Medicine and Science · doi:10.7156/najms.2014.0701008 · Cited by 6
Gut-liver The role of serotonin and its pathways in hepatic fibrogenesis
Stasi, C., Milani, S., & Galli, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00005-x · Cited by 8
Leiszter, K., Galamb, O., Sípos, F., Tóth, K., Valcz, G., Patai, V., Molnár, J., Molnar, B. A., & Tulassay, Z. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28882 · Cited by 6
He, Y., Long, K., Du, B., Liao, W., Zou, R., Su, J., Luo, J., Shi, Z., & Wang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150576 · Cited by 7
Utilising an in silico model to predict outcomes in senescence-driven acute liver injury
Ashmore‐Harris, C., Antonopoulou, E., Aird, R. E., Man, T. Y., Finney, S. M., Speel, A. M., Lu, W., Forbes, S. J., Gadd, V. L., & Waters, S. L. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00371-1 · Cited by 5
“This has been independently validated in samples from patients with viral hepatitis, autoimmune hepatitis, alcohol related liver disease, primary sclerosing cholangitis, primary biliary cirrhosis 22,23 , NAFLD 6 and steatosis 4 .”
BackgroundThe Role of Telomeres in Liver Disease
Sunami, Y., von Figura, G., Kleger, A., Strnad, P., Hüser, N., & Hartmann, D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00007-4 · Cited by 5
Cell Therapy for Liver Disease: From Promise to Reality
Khan, S., Khan, R. S., & Newsome, P. N. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1717096 · Cited by 5
Lester, L. B. (2005) · Humana Press eBooks · doi:10.1385/1592599001 · Cited by 6
Kitsugi, K., Noritake, H., Matsumoto, M., Hanaoka, T., Umemura, M., Yamashita, M., Takatori, S., Ito, J., Ohta, K., Chida, T., et al. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04883-0 · Cited by 6
Tuo, B., Ju, Z., Riederer, B., Engelhardt, R., Manns, M. P., Rudolph, K. L., & Seidler, U. E. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00035.2012 · Cited by 5
Self-citationAffonso, J. M., D'Amico, T. P., Horst, M. A., Moreno, F. S., & Heidor, R. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70088 · Cited by 4
Deciphering the Role of Oroxylin A in Liver Fibrosis
Wang, S., Wu, J., Sun, J., Chen, W., Tian, Z., Huang, S., & Wang, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530387 · Cited by 4
“40 Mitochondrial dysfunction also plays a critical role in hepatocyte senescence.”
el-Din, S. H. S., Hammam, O. A., Ezzat, S. M., Saleh, S., Safar, M. M., El-Maadawy, W. H., & El-Lakkany, N. M. (2023) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.383689 · Cited by 5
Demerdash, H. M., Elyamany, A. S., & Arida, E. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001306 · Cited by 4
Rubromycins: A Class of Telomerase Inhibitor Antibiotics Produced by Streptomyces spp.
Boumehira, A. Z., Hacène, H., & Enshasy, H. A. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-63504-4.00011-6 · Cited by 5
Stem cell research in hepatocellular carcinoma
Sun, C., & Zuo, S. (2008) · Frontiers of Medicine · doi:10.1007/s11684-008-0001-6 · Cited by 4
Telomeres and the ageing process
Woo, J., Suen, E., & Tang, N. L. S. (2010) · Reviews in Clinical Gerontology · doi:10.1017/s0959259809990451 · Cited by 5
Control of Cell Replication during Aging
Macieira‐Coelho, A. (2014) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000358898 · Cited by 4
Laish, I., Mannasse-Green, B., Hadary, R., Konikoff, F. M., Amiel, A., & Kitay‐Cohen, Y. (2016) · Gene · doi:10.1016/j.gene.2016.08.017 · Cited by 5
[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Biliary-derived hepatocytes in chronic liver injury: Bringing new troops to the battlefield?
Aleksieva, N., & Forbes, S. J. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.015 · Cited by 4
“hepatocytes becomes impaired [2][3], leading to failure of the hepatocyte compartment to fully restore normal structure and function.”
BackgroundLiver Progenitor Cells, Cancer Stem Cells and Hepatocellular Carcinoma
Janina, E. E., George, C. T., & John, K. (2012) · InTech eBooks · doi:10.5772/48005 · Cited by 7
“Conversely there is also recent evidence that hepatocytes might reach a state of “replicative senescence” under certain chronic conditions such as advanced cirrhosis, perhaps due to telomere shortening (Paradis et al., 2001; Wiemann et al., 2002).”
BackgroundAnatomy and Physiology of the Biliary Epithelium
Kanz, M. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01004-6 · Cited by 5
Metadata
- Authors
- WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
- Consejo Superior de Investigaciones Científicas (ES)
- Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 9
- Pages
- 935-942
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166704790
- Cited by
- 527
- References
- 34
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
- Deutsche Krebshilfe (10-1809-Ru1)
- Ministerio de Ciencia y Tecnología
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.